Cleared Traditional

K183634 - Stasis Monitoring System

K183634 is the FDA 510(k) clearance for Stasis Monitoring System by Stasis Labs, Inc.. It is a Class 2 Cardiovascular device (product code MWI) cleared through the Traditional 510(k) pathway after a 112-day FDA review.

K183634 · Stasis Labs, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2019
Decision
112d
Days
Class 2
Risk

K183634 is an FDA 510(k) clearance for the Stasis Monitoring System. Classified as Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms) (product code MWI), Class II - Special Controls.

Submitted by Stasis Labs, Inc. (Los Angeles, US). The FDA issued a Cleared decision on April 17, 2019 after a review of 112 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2300 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Stasis Labs, Inc. devices

Submission Details

510(k) Number K183634 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 26, 2018
Decision Date April 17, 2019
Days to Decision 112 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
13d faster than avg
Panel avg: 125d · This submission: 112d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code MWI Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2300
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Consultant

510konsult, LLC
Eric Eggers

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - MWI Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms)

All 123
Devices cleared under the same product code (MWI) and FDA review panel - the closest regulatory comparables to K183634.
DynoSense Vital Sign Measuring System
K190090 · Dynosense Corp. · Aug 2019
Nihon Kohden SVM-7200 Series Vital Signs Monitor
K190468 · Nihon Kohden Corporation · May 2019
Masimo Rad-97 and Accessories
K183697 · Masimo Corporation · May 2019
SmartLinx Vitals Plus Patient Monitoring System
K183638 · Capsule Technologie · Apr 2019
Connect App for iHealth Next, iHealth React Native SDK, iHealth React Native Library SDK, iHealth Library SDK, iHealth Native SDK
K181541 · Andon Health Co, Ltd. · Apr 2019
Patient Monitor
K181919 · Guangdong Biolight Meditech Co., Ltd. · Apr 2019